Relevante Publikationen der Arbeitsgruppe von Prof. Dr. Stahlmann

[Schorsch]

Quelle: https://www.ncbi.nlm.nih.gov/pubmed?cmd ... 0quinolone


Auf Link bzw. Quelle gehen und entsprechende Publikation suchen.


Items: 55



1. Safety issues and drug-drug interactions with commonly used quinolones.


Douros A, Grabowski K, Stahlmann R.

Expert Opin Drug Metab Toxicol. 2015 Jan;11(1):25-39. doi: 10.1517/17425255.2014.970166. Review.


PMID: 25423877

Similar articles

Select item 23651367

2. Risks associated with the therapeutic use of fluoroquinolones.


Stahlmann R, Lode HM.

Expert Opin Drug Saf. 2013 Jul;12(4):497-505. doi: 10.1517/14740338.2013.796362. Review.


PMID: 23651367

Similar articles

Select item 23367659

3. [The eye as target of adverse ocular drug reactions. Focus on systemic antiinfective therapy].


Huber M, Stahlmann R.

Med Monatsschr Pharm. 2012 Dec;35(12):436-42; quiz 443-4. Review. German.


PMID: 23367659

Similar articles

Select item 20210367

4. Safety considerations of fluoroquinolones in the elderly: an update.


Stahlmann R, Lode H.

Drugs Aging. 2010 Mar 1;27(3):193-209. doi: 10.2165/11531490-000000000-00000. Review.


PMID: 20210367

Similar articles

Select item 20034766

5. Synergistic effects of dexamethasone and quinolones on human-derived tendon cells.


Sendzik J, Shakibaei M, Schäfer-Korting M, Lode H, Stahlmann R.

Int J Antimicrob Agents. 2010 Apr;35(4):366-74. doi: 10.1016/j.ijantimicag.2009.10.009.


PMID: 20034766

Similar articles

Select item 19949773

6. Effects of moxifloxacin and clinafloxacin on murine limb buds cultured in regular and in magnesium-deficient medium.


Bode K, Kunz A, Baumann-Wilschke I, Shakibaei M, Stahlmann R.

Arch Toxicol. 2010 Mar;84(3):221-6. doi: 10.1007/s00204-009-0490-3.


PMID: 19949773

Similar articles

Select item 18835137

7. Quinolone-induced arthropathy: an update focusing on new mechanistic and clinical data.


Sendzik J, Lode H, Stahlmann R.

Int J Antimicrob Agents. 2009 Mar;33(3):194-200. doi: 10.1016/j.ijantimicag.2008.08.004. Review.


PMID: 18835137

Similar articles

Select item 18447602

8. Gemifloxacin for community-acquired pneumonia.


Lode HM, Schmidt-Ionas M, Stahlmann R.

Expert Opin Investig Drugs. 2008 May;17(5):779-86. doi: 10.1517/13543784.17.5.779 . Review.


PMID: 18447602

Similar articles

Select item 17210779

9. Diminished ciprofloxacin-induced chondrotoxicity by supplementation with magnesium and vitamin E in immature rats.


Pfister K, Mazur D, Vormann J, Stahlmann R.

Antimicrob Agents Chemother. 2007 Mar;51(3):1022-7.


PMID: 17210779 Free PMC Article

Similar articles

Select item 17119926

10. Effect of quinupristin/dalfopristin on 3T3 and Eahy926 cells in vitro in comparison to other antimicrobial agents with the potential to induce infusion phlebitis.


Kruse M, Kilic B, Flick B, Stahlmann R.

Arch Toxicol. 2007 Jun;81(6):447-52.


PMID: 17119926

Similar articles

Select item 16810628

11. [New antibiotics for the therapy of respiratory tract infections].


Kruse M, Stahlmann R.

Pneumologie. 2006 Jul;60(7):417-27. Review. German.


PMID: 16810628

Similar articles

Select item 16556082

12. Drug interactions during therapy with three major groups of antimicrobial agents.


Shakeri-Nejad K, Stahlmann R.

Expert Opin Pharmacother. 2006 Apr;7(6):639-51. Review.


PMID: 16556082

Similar articles

Select item 16297520

13. The in vitro effects of quinupristin/dalfopristin, erythromycin and levofloxacin at low concentrations on the expression of different cell adhesion molecules on the surface of endothelial cells (Eahy926).


Kilic B, Kruse M, Stahlmann R.

Toxicology. 2006 Jan 20;218(1):30-8.


PMID: 16297520

Similar articles

Select item 15890441

14. Fluoroquinolones cause changes in extracellular matrix, signalling proteins, metalloproteinases and caspase-3 in cultured human tendon cells.


Sendzik J, Shakibaei M, Schäfer-Korting M, Stahlmann R.

Toxicology. 2005 Aug 15;212(1):24-36.


PMID: 15890441

Similar articles

Select item 15336463

15. Safety profile of oral and intravenous moxifloxacin: cumulative data from clinical trials and postmarketing studies.


Ball P, Stahlmann R, Kubin R, Choudhri S, Owens R.

Clin Ther. 2004 Jul;26(7):940-50. Review.


PMID: 15336463

Similar articles

Select item 14661070

16. Concentrations of the des-F(6)-quinolone garenoxacin in plasma and joint cartilage of immature rats.


Kastner M, Rahm U, Baumann-Wilschke I, Bello A, Stahlmann R.

Arch Toxicol. 2004 Feb;78(2):61-7.


PMID: 14661070

Similar articles

Select item 12811465

17. Ultrastructural changes induced by the des-F(6)-quinolone garenoxacin (BMS-284756) and two fluoroquinolones in Achilles tendon from immature rats.


Shakibaei M, Stahlmann R.

Arch Toxicol. 2003 Sep;77(9):521-6.


PMID: 12811465

Similar articles

Select item 12641485

18. Fluoroquinolones in the elderly: safety considerations.


Stahlmann R, Lode H.

Drugs Aging. 2003;20(4):289-302. Review.


PMID: 12641485

Similar articles

Select item 12491034

19. Children as a special population at risk--quinolones as an example for xenobiotics exhibiting skeletal toxicity.


Stahlmann R.

Arch Toxicol. 2003 Jan;77(1):7-11. Review.


PMID: 12491034

Similar articles

Select item 12234871

20. Effects of the Des-F(6)-quinolone garenoxacin (BMS-284756), in comparison to those of ciprofloxacin and ofloxacin, on joint cartilage in immature rats.


Kappel EM, Shakibaei M, Bello A, Stahlmann R.

Antimicrob Agents Chemother. 2002 Oct;46(10):3320-2.


PMID: 12234871 Free PMC Article

Similar articles

Select item 12052667

21. Clinical toxicological aspects of fluoroquinolones.


Stahlmann R.

Toxicol Lett. 2002 Feb 28;127(1-3):269-77.


PMID: 12052667

Similar articles

Select item 12019086

22. Synergistic effect of ofloxacin and magnesium deficiency on joint cartilage in immature rats.


Lozo E, Riecke K, Schwabe R, Vormann J, Stahlmann R.

Antimicrob Agents Chemother. 2002 Jun;46(6):1755-9.


PMID: 12019086 Free PMC Article

Similar articles

Select item 11876506

23. Ultrastructural characterization of murine limb buds after in vitro exposure to grepafloxacin and other fluoroquinolones.


Shakibaei M, Baumann-Wilschke I, Rücker M, Stahlmann R.

Arch Toxicol. 2002 Jan;75(11-12):725-33.


PMID: 11876506

Similar articles

Select item 11575178

24. [Well tolerated or risky? Adverse effect of quinolones].


Stahlmann R, Riecke K.

Pharm Unserer Zeit. 2001;30(5):412-7. Review. German. No abstract available.


PMID: 11575178

Similar articles

Select item 11570695

25. Biochemical changes in Achilles tendon from juvenile dogs after treatment with ciprofloxacin or feeding a magnesium-deficient diet.


Shakibaei M, de Souza P, van Sickle D, Stahlmann R.

Arch Toxicol. 2001 Aug;75(6):369-74.


PMID: 11570695

Similar articles

Select item 11357519

26. Effects of fluoroquinolones on the locomotor activity in rats.


Thiel R, Metzner S, Gericke C, Rahm U, Stahlmann R.

Arch Toxicol. 2001 Mar;75(1):36-41.


PMID: 11357519

Similar articles

Select item 11354912

27. Ultrastructure of Achilles tendon from rats after treatment with fleroxacin.


Shakibaei M, Stahlmann R.

Arch Toxicol. 2001 Apr;75(2):97-102.


PMID: 11354912

Similar articles

Select item 10912165

28. [Recent fluoroquinolones. Highly effective weapons for ambulatory therapy].


Stahlmann R, Lode H.

MMW Fortschr Med. 1999 Nov 25;141(47):35-6. German. No abstract available.


PMID: 10912165

Similar articles

Select item 10663389

29. Effects of magnesium deficiency on joint cartilage in immature beagle dogs: immunohistochemistry, electron microscopy, and mineral concentrations.


Stahlmann R, Kühner S, Shakibaei M, Flores J, Vormann J, van Sickle DC.

Arch Toxicol. 2000 Jan;73(10-11):573-80.


PMID: 10663389

Similar articles

Select item 10663388

30. Chondrotoxicity of ciprofloxacin in immature beagle dogs: immunohistochemistry, electron microscopy and drug plasma concentrations.


Stahlmann R, Kühner S, Shakibaei M, Schwabe R, Flores J, Evander SA, van Sickle DC.

Arch Toxicol. 2000 Jan;73(10-11):564-72.


PMID: 10663388

Similar articles

Select item 10639347

31. Ultrastructure of Achilles tendons of rats treated with ofloxacin and fed a normal or magnesium-deficient diet.


Shakibaei M, Pfister K, Schwabe R, Vormann J, Stahlmann R.

Antimicrob Agents Chemother. 2000 Feb;44(2):261-6.


PMID: 10639347 Free PMC Article

Similar articles

Select item 10613068

32. [Fluoroquinolones in the treatment of respiratory infections].


Stahlmann R.

Pneumologie. 1999 Nov;53(11):521-9. Review. German. No abstract available.


PMID: 10613068

Similar articles

Select item 10553703

33. Toxicity of quinolones.


Stahlmann R, Lode H.

Drugs. 1999;58 Suppl 2:37-42. Review.


PMID: 10553703

Similar articles

Select item 9788487

34. Safety of quinolones.


Stahlmann R, Lode H.

Lancet. 1998 Oct 17;352(9136):1313. No abstract available.


PMID: 9788487

Similar articles

Select item 9708880

35. Effects of fluoroquinolones and magnesium deficiency in murine limb bud cultures.


Förster C, Rücker M, Shakibaei M, Baumann-Wilschke I, Vormann J, Stahlmann R.

Arch Toxicol. 1998 Jun;72(7):411-9.


PMID: 9708880

Similar articles

Select item 9624496

36. Chondrotoxicity and toxicokinetics of sparfloxacin in juvenile rats.


Stahlmann R, Zippel U, Förster C, Schwabe R, Shakibaei M, Merker HJ, Borner K.

Antimicrob Agents Chemother. 1998 Jun;42(6):1470-5.


PMID: 9624496 Free PMC Article

Similar articles

Select item 9484877

37. Safety profile of grepafloxacin compared with other fluoroquinolones.


Stahlmann R, Schwabe R.

J Antimicrob Chemother. 1997 Dec;40 Suppl A:83-92. Review.


PMID: 9484877 Free Article

Similar articles

Select item 9323837

38. Immunohistochemistry of articular cartilage from immature beagle dogs dosed with difloxacin.


Burkhardt JE, Förster C, Lozo E, Hill MA, Stahlmann R.

Toxicol Pathol. 1997 Sep-Oct;25(5):475-80.


PMID: 9323837 Free Article

Similar articles

Select item 9262515

39. Effects of magnesium deficiency on magnesium and calcium content in bone and cartilage in developing rats in correlation to chondrotoxicity.


Vormann J, Förster C, Zippel U, Lozo E, Günther T, Merker H, Stahlmann R.

Calcif Tissue Int. 1997 Sep;61(3):230-8.


PMID: 9262515

Similar articles

Select item 9458187

40. Quinolone-induced arthropathy: exposure of magnesium-deficient aged rats or immature rats, mineral concentrations in target tissues and pharmacokinetics.


Förster C, Schwabe R, Lozo E, Zippel U, Vormann J, Günther T, Merker HJ, Stahlmann R.

Arch Toxicol. 1997;72(1):26-32.


PMID: 9458187

Similar articles

Select item 9209695

41. In vitro evidence for a Donnan distribution of Mg2+ and Ca2+ by chondroitin sulphate in cartilage.


Günther T, Rücker M, Förster C, Vormann J, Stahlmann R.

Arch Toxicol. 1997;71(7):471-5.


PMID: 9209695

Similar articles

Select item 9138627

42. The developmental toxicity of three antimicrobial agents observed only in nonroutine animal studies.


Stahlmann R, Chahoud I, Thiel R, Klug S, Förster C.

Reprod Toxicol. 1997 Jan-Feb;11(1):1-7. Review. No abstract available.


PMID: 9138627

Similar articles

Select item 8923679

43. Comparative evaluation of ultrastructural changes in articular cartilage of ofloxacin-treated and magnesium-deficient immature rats.


Shakibaei M, Kociok K, Förster C, Vormann J, Günther T, Stahlmann R, Merker HJ.

Toxicol Pathol. 1996 Sep-Oct;24(5):580-7.


PMID: 8923679 Free Article

Similar articles

Select item 8852696

44. Integrins on joint cartilage chondrocytes and alterations by ofloxacin or magnesium deficiency in immature rats.


Förster C, Kociok K, Shakibaei M, Merker HJ, Vormann J, Günther T, Stahlmann R.

Arch Toxicol. 1996;70(5):261-70.


PMID: 8852696

Similar articles

Select item 8783810

45. Quinolone-induced cartilage lesions are not reversible in rats.


Förster C, Kociok K, Shakibaei M, Merker HJ, Stahlmann R.

Arch Toxicol. 1996;70(8):474-81.


PMID: 8783810

Similar articles

Select item 7503804

46. Enoxacin is an inducer of CYP1A2 in rat liver.


Schulz TG, Stahlmann R, Edwards RJ, Debri K, Davies DS, Neubert D.

Biochem Pharmacol. 1995 Oct 26;50(9):1517-20.


PMID: 7503804

Similar articles

Select item 8540708

47. Magnesium deficiency induces joint cartilage lesions in juvenile rats which are identical to quinolone-induced arthropathy.


Stahlmann R, Förster C, Shakibaei M, Vormann J, Günther T, Merker HJ.

Antimicrob Agents Chemother. 1995 Sep;39(9):2013-8.


PMID: 8540708 Free PMC Article

Similar articles

Select item 20650069

48. Effects of ofloxacin on integrin expression on epiphyseal mouse chondrocytes in vitro.


Shakibaei M, Förster C, Merker HJ, Stahlmann R.

Toxicol In Vitro. 1995 Apr;9(2):107-16.


PMID: 20650069

Similar articles

Select item 8549338

49. Ofloxacin alters expression of integrins on chondrocytes from mouse fetuses in vitro.


Shakibaei M, Förster C, Merker HJ, Stahlmann R.

Drugs. 1995;49 Suppl 2:293-5. No abstract available.


PMID: 8549338

Similar articles

Select item 8549332

50. Expression of beta 1-integrins on epiphyseal chondrocytes is reduced by ofloxacin.


Förster C, Shakibaei M, Schilcher H, Stahlmann R.

Drugs. 1995;49 Suppl 2:279-82. No abstract available.


PMID: 8549332

Similar articles

Select item 8129861

51. Quinolones in children. Are concerns over arthropathy justified?


Stahlmann R, Förster C, Van Sickle D.

Drug Saf. 1993 Dec;9(6):397-403. Review. No abstract available.


PMID: 8129861

Similar articles

Select item 2007514

52. [Cartilage-damaging effect of quinolones].


Stahlmann R.

Infection. 1991;19 Suppl 1:S38-46. Review. German.


PMID: 2007514

Similar articles

Select item 2290386

53. [Drug interactions with quinolones. Modification of hepatic monooxygenases as the cause].


Schulz-Schalge T, Stahlmann R.

Med Monatsschr Pharm. 1990 Dec;13(12):372-81. Review. German. No abstract available.


PMID: 2290386

Similar articles

Select item 2286589

54. Safety profile of the quinolones.


Stahlmann R.

J Antimicrob Chemother. 1990 Nov;26 Suppl D:31-44. Review.


PMID: 2286589

Similar articles

Select item 2115323


55. Ofloxacin in juvenile non-human primates and rats. Arthropathia and drug plasma concentrations.


Stahlmann R, Merker HJ, Hinz N, Chahoud I, Webb J, Heger W, Neubert D.

Arch Toxicol. 1990;64(3):193-204.